Bio-Rad Laboratories | BIO - 当期純利益





当期純利益 変化する 日付
Abbott USD 928M 149M 2026-06
Agilent USD 362M 23M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Bio Techne USD 51.05M 13.04M 2026-03
Bio-Rad Laboratories USD 371.4M 898.5M 2026-06
Bruker USD -62.9M 66.4M 2026-06
Charles River Laboratories USD -1.48M 13.36M 2026-06
Danaher USD 870M 159M 2026-06
General Electric Aerospace USD 2.37B 466M 2026-06
Illumina USD 207M 73M 2026-06
IQVIA Holdings USD 256M 18M 2026-06
Laboratory Of America USD 298.7M 20.9M 2026-06
Merck USD -1.34B 2.9B 2026-06
Mettler Toledo International USD 232.9M 63.44M 2026-06
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 320M 69M 2026-06
Repligen USD 5.01M 3.32M 2026-06
Revvity USD 51.82M 11.1M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Siemens EUR 2.27B 243M 2026-06
Standard Biotools USD 127.07M 107.78M 2026-03
Thermo Fisher Scientific USD 1.74B 85M 2026-06
Tosoh JPY 19.46B 2.47B 2026-06
Waters USD -136M 64M 2026-06